Optimvia is a biopharmaceutical company that specializes in engineering proteins with tailored functions to combat disease.
Optimvia has raised $523K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2024.
Optimvia is headquartered in Cincinnati, United States.
Optimvia is a biopharmaceutical company that specializes in engineering proteins with tailored functions to combat disease.
Optimvia is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Optimvia — Funding & Investors." VCBacked, August 27, 2024, https://www.vcbacked.co/company/optimvia. Accessed August 15, 2026.
VCBacked. (2024). Optimvia — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/optimvia
{{cite web |title=Optimvia — Funding & Investors |url=https://www.vcbacked.co/company/optimvia |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated